In-Vitro Diagnostics Industry Research Report 2024
Summary
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report? we counted In-Vitro Diagnostics reagent.
According to APO Research, The global In-Vitro Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of In-Vitro Diagnostics include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD and JNJ, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In-Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Diagnostics.
The In-Vitro Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of In-Vitro Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report? we counted In-Vitro Diagnostics reagent.
According to APO Research, The global In-Vitro Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of In-Vitro Diagnostics include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD and JNJ, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In-Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Diagnostics.
The In-Vitro Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Roche
- Siemens
- Abbott
- Danaher
- Thermo Fisher
- BioMerieux
- Bio-Rad
- BD
- JNJ
- Sysmex
- KHB
- DaAn Gene
- Leadman
- BioSino
- BSBE
- Maccura
- Tissue Diagnostics
- Professional Diagnostic
- Molecular Diagnostic
- Diabetes Monitoring
- Other
- Diabetes
- Infectious Diseases
- Oncology
- Cardiology
- HIV
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of In-Vitro Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 In-Vitro Diagnostics by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Tissue Diagnostics
2.2.3 Professional Diagnostic
2.2.4 Molecular Diagnostic
2.2.5 Diabetes Monitoring
2.2.6 Other
2.3 In-Vitro Diagnostics by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Diabetes
2.3.3 Infectious Diseases
2.3.4 Oncology
2.3.5 Cardiology
2.3.6 HIV
2.3.7 Other
2.4 Assumptions and Limitations
3 IN-VITRO DIAGNOSTICS BREAKDOWN DATA BY TYPE
3.1 Global In-Vitro Diagnostics Historic Market Size by Type (2019-2024)
3.2 Global In-Vitro Diagnostics Forecasted Market Size by Type (2025-2030)
4 IN-VITRO DIAGNOSTICS BREAKDOWN DATA BY APPLICATION
4.1 Global In-Vitro Diagnostics Historic Market Size by Application (2019-2024)
4.2 Global In-Vitro Diagnostics Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global In-Vitro Diagnostics Market Perspective (2019-2030)
5.2 Global In-Vitro Diagnostics Growth Trends by Region
5.2.1 Global In-Vitro Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 In-Vitro Diagnostics Historic Market Size by Region (2019-2024)
5.2.3 In-Vitro Diagnostics Forecasted Market Size by Region (2025-2030)
5.3 In-Vitro Diagnostics Market Dynamics
5.3.1 In-Vitro Diagnostics Industry Trends
5.3.2 In-Vitro Diagnostics Market Drivers
5.3.3 In-Vitro Diagnostics Market Challenges
5.3.4 In-Vitro Diagnostics Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top In-Vitro Diagnostics Players by Revenue
6.1.1 Global Top In-Vitro Diagnostics Players by Revenue (2019-2024)
6.1.2 Global In-Vitro Diagnostics Revenue Market Share by Players (2019-2024)
6.2 Global In-Vitro Diagnostics Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of In-Vitro Diagnostics Head office and Area Served
6.4 Global In-Vitro Diagnostics Players, Product Type & Application
6.5 Global In-Vitro Diagnostics Players, Date of Enter into This Industry
6.6 Global In-Vitro Diagnostics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America In-Vitro Diagnostics Market Size (2019-2030)
7.2 North America In-Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America In-Vitro Diagnostics Market Size by Country (2019-2024)
7.4 North America In-Vitro Diagnostics Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe In-Vitro Diagnostics Market Size (2019-2030)
8.2 Europe In-Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe In-Vitro Diagnostics Market Size by Country (2019-2024)
8.4 Europe In-Vitro Diagnostics Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific In-Vitro Diagnostics Market Size (2019-2030)
9.2 Asia-Pacific In-Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific In-Vitro Diagnostics Market Size by Country (2019-2024)
9.4 Asia-Pacific In-Vitro Diagnostics Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America In-Vitro Diagnostics Market Size (2019-2030)
10.2 Latin America In-Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America In-Vitro Diagnostics Market Size by Country (2019-2024)
10.4 Latin America In-Vitro Diagnostics Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa In-Vitro Diagnostics Market Size (2019-2030)
11.2 Middle East & Africa In-Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa In-Vitro Diagnostics Market Size by Country (2019-2024)
11.4 Middle East & Africa In-Vitro Diagnostics Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Roche
12.1.1 Roche Company Information
12.1.2 Roche Business Overview
12.1.3 Roche Revenue in In-Vitro Diagnostics Business (2019-2024)
12.1.4 Roche In-Vitro Diagnostics Product Portfolio
12.1.5 Roche Recent Developments
12.2 Siemens
12.2.1 Siemens Company Information
12.2.2 Siemens Business Overview
12.2.3 Siemens Revenue in In-Vitro Diagnostics Business (2019-2024)
12.2.4 Siemens In-Vitro Diagnostics Product Portfolio
12.2.5 Siemens Recent Developments
12.3 Abbott
12.3.1 Abbott Company Information
12.3.2 Abbott Business Overview
12.3.3 Abbott Revenue in In-Vitro Diagnostics Business (2019-2024)
12.3.4 Abbott In-Vitro Diagnostics Product Portfolio
12.3.5 Abbott Recent Developments
12.4 Danaher
12.4.1 Danaher Company Information
12.4.2 Danaher Business Overview
12.4.3 Danaher Revenue in In-Vitro Diagnostics Business (2019-2024)
12.4.4 Danaher In-Vitro Diagnostics Product Portfolio
12.4.5 Danaher Recent Developments
12.5 Thermo Fisher
12.5.1 Thermo Fisher Company Information
12.5.2 Thermo Fisher Business Overview
12.5.3 Thermo Fisher Revenue in In-Vitro Diagnostics Business (2019-2024)
12.5.4 Thermo Fisher In-Vitro Diagnostics Product Portfolio
12.5.5 Thermo Fisher Recent Developments
12.6 BioMerieux
12.6.1 BioMerieux Company Information
12.6.2 BioMerieux Business Overview
12.6.3 BioMerieux Revenue in In-Vitro Diagnostics Business (2019-2024)
12.6.4 BioMerieux In-Vitro Diagnostics Product Portfolio
12.6.5 BioMerieux Recent Developments
12.7 Bio-Rad
12.7.1 Bio-Rad Company Information
12.7.2 Bio-Rad Business Overview
12.7.3 Bio-Rad Revenue in In-Vitro Diagnostics Business (2019-2024)
12.7.4 Bio-Rad In-Vitro Diagnostics Product Portfolio
12.7.5 Bio-Rad Recent Developments
12.8 BD
12.8.1 BD Company Information
12.8.2 BD Business Overview
12.8.3 BD Revenue in In-Vitro Diagnostics Business (2019-2024)
12.8.4 BD In-Vitro Diagnostics Product Portfolio
12.8.5 BD Recent Developments
12.9 JNJ
12.9.1 JNJ Company Information
12.9.2 JNJ Business Overview
12.9.3 JNJ Revenue in In-Vitro Diagnostics Business (2019-2024)
12.9.4 JNJ In-Vitro Diagnostics Product Portfolio
12.9.5 JNJ Recent Developments
12.10 Sysmex
12.10.1 Sysmex Company Information
12.10.2 Sysmex Business Overview
12.10.3 Sysmex Revenue in In-Vitro Diagnostics Business (2019-2024)
12.10.4 Sysmex In-Vitro Diagnostics Product Portfolio
12.10.5 Sysmex Recent Developments
12.11 KHB
12.11.1 KHB Company Information
12.11.2 KHB Business Overview
12.11.3 KHB Revenue in In-Vitro Diagnostics Business (2019-2024)
12.11.4 KHB In-Vitro Diagnostics Product Portfolio
12.11.5 KHB Recent Developments
12.12 DaAn Gene
12.12.1 DaAn Gene Company Information
12.12.2 DaAn Gene Business Overview
12.12.3 DaAn Gene Revenue in In-Vitro Diagnostics Business (2019-2024)
12.12.4 DaAn Gene In-Vitro Diagnostics Product Portfolio
12.12.5 DaAn Gene Recent Developments
12.13 Leadman
12.13.1 Leadman Company Information
12.13.2 Leadman Business Overview
12.13.3 Leadman Revenue in In-Vitro Diagnostics Business (2019-2024)
12.13.4 Leadman In-Vitro Diagnostics Product Portfolio
12.13.5 Leadman Recent Developments
12.14 BioSino
12.14.1 BioSino Company Information
12.14.2 BioSino Business Overview
12.14.3 BioSino Revenue in In-Vitro Diagnostics Business (2019-2024)
12.14.4 BioSino In-Vitro Diagnostics Product Portfolio
12.14.5 BioSino Recent Developments
12.15 BSBE
12.15.1 BSBE Company Information
12.15.2 BSBE Business Overview
12.15.3 BSBE Revenue in In-Vitro Diagnostics Business (2019-2024)
12.15.4 BSBE In-Vitro Diagnostics Product Portfolio
12.15.5 BSBE Recent Developments
12.16 Maccura
12.16.1 Maccura Company Information
12.16.2 Maccura Business Overview
12.16.3 Maccura Revenue in In-Vitro Diagnostics Business (2019-2024)
12.16.4 Maccura In-Vitro Diagnostics Product Portfolio
12.16.5 Maccura Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 In-Vitro Diagnostics by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Tissue Diagnostics
2.2.3 Professional Diagnostic
2.2.4 Molecular Diagnostic
2.2.5 Diabetes Monitoring
2.2.6 Other
2.3 In-Vitro Diagnostics by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Diabetes
2.3.3 Infectious Diseases
2.3.4 Oncology
2.3.5 Cardiology
2.3.6 HIV
2.3.7 Other
2.4 Assumptions and Limitations
3 IN-VITRO DIAGNOSTICS BREAKDOWN DATA BY TYPE
3.1 Global In-Vitro Diagnostics Historic Market Size by Type (2019-2024)
3.2 Global In-Vitro Diagnostics Forecasted Market Size by Type (2025-2030)
4 IN-VITRO DIAGNOSTICS BREAKDOWN DATA BY APPLICATION
4.1 Global In-Vitro Diagnostics Historic Market Size by Application (2019-2024)
4.2 Global In-Vitro Diagnostics Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global In-Vitro Diagnostics Market Perspective (2019-2030)
5.2 Global In-Vitro Diagnostics Growth Trends by Region
5.2.1 Global In-Vitro Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 In-Vitro Diagnostics Historic Market Size by Region (2019-2024)
5.2.3 In-Vitro Diagnostics Forecasted Market Size by Region (2025-2030)
5.3 In-Vitro Diagnostics Market Dynamics
5.3.1 In-Vitro Diagnostics Industry Trends
5.3.2 In-Vitro Diagnostics Market Drivers
5.3.3 In-Vitro Diagnostics Market Challenges
5.3.4 In-Vitro Diagnostics Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top In-Vitro Diagnostics Players by Revenue
6.1.1 Global Top In-Vitro Diagnostics Players by Revenue (2019-2024)
6.1.2 Global In-Vitro Diagnostics Revenue Market Share by Players (2019-2024)
6.2 Global In-Vitro Diagnostics Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of In-Vitro Diagnostics Head office and Area Served
6.4 Global In-Vitro Diagnostics Players, Product Type & Application
6.5 Global In-Vitro Diagnostics Players, Date of Enter into This Industry
6.6 Global In-Vitro Diagnostics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America In-Vitro Diagnostics Market Size (2019-2030)
7.2 North America In-Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America In-Vitro Diagnostics Market Size by Country (2019-2024)
7.4 North America In-Vitro Diagnostics Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe In-Vitro Diagnostics Market Size (2019-2030)
8.2 Europe In-Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe In-Vitro Diagnostics Market Size by Country (2019-2024)
8.4 Europe In-Vitro Diagnostics Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific In-Vitro Diagnostics Market Size (2019-2030)
9.2 Asia-Pacific In-Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific In-Vitro Diagnostics Market Size by Country (2019-2024)
9.4 Asia-Pacific In-Vitro Diagnostics Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America In-Vitro Diagnostics Market Size (2019-2030)
10.2 Latin America In-Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America In-Vitro Diagnostics Market Size by Country (2019-2024)
10.4 Latin America In-Vitro Diagnostics Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa In-Vitro Diagnostics Market Size (2019-2030)
11.2 Middle East & Africa In-Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa In-Vitro Diagnostics Market Size by Country (2019-2024)
11.4 Middle East & Africa In-Vitro Diagnostics Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Roche
12.1.1 Roche Company Information
12.1.2 Roche Business Overview
12.1.3 Roche Revenue in In-Vitro Diagnostics Business (2019-2024)
12.1.4 Roche In-Vitro Diagnostics Product Portfolio
12.1.5 Roche Recent Developments
12.2 Siemens
12.2.1 Siemens Company Information
12.2.2 Siemens Business Overview
12.2.3 Siemens Revenue in In-Vitro Diagnostics Business (2019-2024)
12.2.4 Siemens In-Vitro Diagnostics Product Portfolio
12.2.5 Siemens Recent Developments
12.3 Abbott
12.3.1 Abbott Company Information
12.3.2 Abbott Business Overview
12.3.3 Abbott Revenue in In-Vitro Diagnostics Business (2019-2024)
12.3.4 Abbott In-Vitro Diagnostics Product Portfolio
12.3.5 Abbott Recent Developments
12.4 Danaher
12.4.1 Danaher Company Information
12.4.2 Danaher Business Overview
12.4.3 Danaher Revenue in In-Vitro Diagnostics Business (2019-2024)
12.4.4 Danaher In-Vitro Diagnostics Product Portfolio
12.4.5 Danaher Recent Developments
12.5 Thermo Fisher
12.5.1 Thermo Fisher Company Information
12.5.2 Thermo Fisher Business Overview
12.5.3 Thermo Fisher Revenue in In-Vitro Diagnostics Business (2019-2024)
12.5.4 Thermo Fisher In-Vitro Diagnostics Product Portfolio
12.5.5 Thermo Fisher Recent Developments
12.6 BioMerieux
12.6.1 BioMerieux Company Information
12.6.2 BioMerieux Business Overview
12.6.3 BioMerieux Revenue in In-Vitro Diagnostics Business (2019-2024)
12.6.4 BioMerieux In-Vitro Diagnostics Product Portfolio
12.6.5 BioMerieux Recent Developments
12.7 Bio-Rad
12.7.1 Bio-Rad Company Information
12.7.2 Bio-Rad Business Overview
12.7.3 Bio-Rad Revenue in In-Vitro Diagnostics Business (2019-2024)
12.7.4 Bio-Rad In-Vitro Diagnostics Product Portfolio
12.7.5 Bio-Rad Recent Developments
12.8 BD
12.8.1 BD Company Information
12.8.2 BD Business Overview
12.8.3 BD Revenue in In-Vitro Diagnostics Business (2019-2024)
12.8.4 BD In-Vitro Diagnostics Product Portfolio
12.8.5 BD Recent Developments
12.9 JNJ
12.9.1 JNJ Company Information
12.9.2 JNJ Business Overview
12.9.3 JNJ Revenue in In-Vitro Diagnostics Business (2019-2024)
12.9.4 JNJ In-Vitro Diagnostics Product Portfolio
12.9.5 JNJ Recent Developments
12.10 Sysmex
12.10.1 Sysmex Company Information
12.10.2 Sysmex Business Overview
12.10.3 Sysmex Revenue in In-Vitro Diagnostics Business (2019-2024)
12.10.4 Sysmex In-Vitro Diagnostics Product Portfolio
12.10.5 Sysmex Recent Developments
12.11 KHB
12.11.1 KHB Company Information
12.11.2 KHB Business Overview
12.11.3 KHB Revenue in In-Vitro Diagnostics Business (2019-2024)
12.11.4 KHB In-Vitro Diagnostics Product Portfolio
12.11.5 KHB Recent Developments
12.12 DaAn Gene
12.12.1 DaAn Gene Company Information
12.12.2 DaAn Gene Business Overview
12.12.3 DaAn Gene Revenue in In-Vitro Diagnostics Business (2019-2024)
12.12.4 DaAn Gene In-Vitro Diagnostics Product Portfolio
12.12.5 DaAn Gene Recent Developments
12.13 Leadman
12.13.1 Leadman Company Information
12.13.2 Leadman Business Overview
12.13.3 Leadman Revenue in In-Vitro Diagnostics Business (2019-2024)
12.13.4 Leadman In-Vitro Diagnostics Product Portfolio
12.13.5 Leadman Recent Developments
12.14 BioSino
12.14.1 BioSino Company Information
12.14.2 BioSino Business Overview
12.14.3 BioSino Revenue in In-Vitro Diagnostics Business (2019-2024)
12.14.4 BioSino In-Vitro Diagnostics Product Portfolio
12.14.5 BioSino Recent Developments
12.15 BSBE
12.15.1 BSBE Company Information
12.15.2 BSBE Business Overview
12.15.3 BSBE Revenue in In-Vitro Diagnostics Business (2019-2024)
12.15.4 BSBE In-Vitro Diagnostics Product Portfolio
12.15.5 BSBE Recent Developments
12.16 Maccura
12.16.1 Maccura Company Information
12.16.2 Maccura Business Overview
12.16.3 Maccura Revenue in In-Vitro Diagnostics Business (2019-2024)
12.16.4 Maccura In-Vitro Diagnostics Product Portfolio
12.16.5 Maccura Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global In-Vitro Diagnostics Revenue Market Share by Type (2018-2023)
Table 7. Global In-Vitro Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global In-Vitro Diagnostics Revenue Market Share by Type (2024-2029)
Table 9. Global In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global In-Vitro Diagnostics Revenue Market Share by Application (2018-2023)
Table 11. Global In-Vitro Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global In-Vitro Diagnostics Revenue Market Share by Application (2024-2029)
Table 13. Global In-Vitro Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global In-Vitro Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global In-Vitro Diagnostics Market Share by Region (2018-2023)
Table 16. Global In-Vitro Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global In-Vitro Diagnostics Market Share by Region (2024-2029)
Table 18. In-Vitro Diagnostics Market Trends
Table 19. In-Vitro Diagnostics Market Drivers
Table 20. In-Vitro Diagnostics Market Challenges
Table 21. In-Vitro Diagnostics Market Restraints
Table 22. Global Top In-Vitro Diagnostics Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global In-Vitro Diagnostics Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global In-Vitro Diagnostics Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of In-Vitro Diagnostics, Headquarters and Area Served
Table 26. Global In-Vitro Diagnostics Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global In-Vitro Diagnostics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 45. Roche Company Detail
Table 46. Roche Business Overview
Table 47. Roche In-Vitro Diagnostics Product
Table 48. Roche Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 49. Roche Recent Development
Table 50. Siemens Company Detail
Table 51. Siemens Business Overview
Table 52. Siemens In-Vitro Diagnostics Product
Table 53. Siemens Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 54. Siemens Recent Development
Table 55. Abbott Company Detail
Table 56. Abbott Business Overview
Table 57. Abbott In-Vitro Diagnostics Product
Table 58. Abbott Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 59. Abbott Recent Development
Table 60. Danaher Company Detail
Table 61. Danaher Business Overview
Table 62. Danaher In-Vitro Diagnostics Product
Table 63. Danaher Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 64. Danaher Recent Development
Table 65. Thermo Fisher Company Detail
Table 66. Thermo Fisher Business Overview
Table 67. Thermo Fisher In-Vitro Diagnostics Product
Table 68. Thermo Fisher Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 69. Thermo Fisher Recent Development
Table 70. BioMerieux Company Detail
Table 71. BioMerieux Business Overview
Table 72. BioMerieux In-Vitro Diagnostics Product
Table 73. BioMerieux Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 74. BioMerieux Recent Development
Table 75. Bio-Rad Company Detail
Table 76. Bio-Rad Business Overview
Table 77. Bio-Rad In-Vitro Diagnostics Product
Table 78. Bio-Rad Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 79. Bio-Rad Recent Development
Table 80. BD Company Detail
Table 81. BD Business Overview
Table 82. BD In-Vitro Diagnostics Product
Table 83. BD Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 84. BD Recent Development
Table 85. JNJ Company Detail
Table 86. JNJ Business Overview
Table 87. JNJ In-Vitro Diagnostics Product
Table 88. JNJ Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 89. JNJ Recent Development
Table 90. Sysmex Company Detail
Table 91. Sysmex Business Overview
Table 92. Sysmex In-Vitro Diagnostics Product
Table 93. Sysmex Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 94. Sysmex Recent Development
Table 95. KHB Company Detail
Table 96. KHB Business Overview
Table 97. KHB In-Vitro DiagnosticsProduct
Table 98. KHB Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 99. KHB Recent Development
Table 100. DaAn Gene Company Detail
Table 101. DaAn Gene Business Overview
Table 102. DaAn Gene In-Vitro DiagnosticsProduct
Table 103. DaAn Gene Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 104. DaAn Gene Recent Development
Table 105. Leadman Company Detail
Table 106. Leadman Business Overview
Table 107. Leadman In-Vitro DiagnosticsProduct
Table 108. Leadman Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 109. Leadman Recent Development
Table 110. BioSino Company Detail
Table 111. BioSino Business Overview
Table 112. BioSino In-Vitro DiagnosticsProduct
Table 113. BioSino Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 114. BioSino Recent Development
Table 115. BSBE Company Detail
Table 116. BSBE Business Overview
Table 117. BSBE In-Vitro DiagnosticsProduct
Table 118. BSBE Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 119. BSBE Recent Development
Table 120. Maccura Company Detail
Table 121. Maccura Business Overview
Table 122. Maccura In-Vitro DiagnosticsProduct
Table 123. Maccura Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 124. Maccura Recent Development
Table 125. Roche Company Information
Table 126. Roche Business Overview
Table 127. Roche In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 128. Roche Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 129. Roche Recent Development
Table 130. Siemens Company Information
Table 131. Siemens Business Overview
Table 132. Siemens In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 133. Siemens Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 134. Siemens Recent Development
Table 135. Abbott Company Information
Table 136. Abbott Business Overview
Table 137. Abbott In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 138. Abbott Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 139. Abbott Recent Development
Table 140. Danaher Company Information
Table 141. Danaher Business Overview
Table 142. Danaher In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 143. Danaher Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 144. Danaher Recent Development
Table 145. Thermo Fisher Company Information
Table 146. Thermo Fisher Business Overview
Table 147. Thermo Fisher In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 148. Thermo Fisher Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 149. Thermo Fisher Recent Development
Table 150. BioMerieux Company Information
Table 151. BioMerieux Business Overview
Table 152. BioMerieux In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 153. BioMerieux Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 154. BioMerieux Recent Development
Table 155. Bio-Rad Company Information
Table 156. Bio-Rad Business Overview
Table 157. Bio-Rad In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 158. Bio-Rad Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 159. Bio-Rad Recent Development
Table 160. BD Company Information
Table 161. BD Business Overview
Table 162. BD In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 163. BD Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 164. BD Recent Development
Table 165. JNJ Company Information
Table 166. JNJ Business Overview
Table 167. JNJ In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 168. JNJ Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 169. JNJ Recent Development
Table 170. Sysmex Company Information
Table 171. Sysmex Business Overview
Table 172. Sysmex In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 173. Sysmex Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 174. Sysmex Recent Development
Table 175. KHB Company Information
Table 176. KHB Business Overview
Table 177. KHB In-Vitro DiagnosticsRevenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 178. KHB Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 179. KHB Recent Development
Table 180. DaAn Gene Company Information
Table 181. DaAn Gene Business Overview
Table 182. DaAn Gene In-Vitro DiagnosticsRevenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 183. DaAn Gene Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 184. DaAn Gene Recent Development
Table 185. Leadman Company Information
Table 186. Leadman Business Overview
Table 187. Leadman In-Vitro DiagnosticsRevenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 188. Leadman Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 189. Leadman Recent Development
Table 190. BioSino Company Information
Table 191. BioSino Business Overview
Table 192. BioSino In-Vitro DiagnosticsRevenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 193. BioSino Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 194. BioSino Recent Development
Table 195. BSBE Company Information
Table 196. BSBE Business Overview
Table 197. BSBE In-Vitro DiagnosticsRevenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 198. BSBE Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 199. BSBE Recent Development
Table 200. Maccura Company Information
Table 201. Maccura Business Overview
Table 202. Maccura In-Vitro DiagnosticsRevenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 203. Maccura Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 204. Maccura Recent Development
Table 205. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global In-Vitro Diagnostics Revenue Market Share by Type (2018-2023)
Table 7. Global In-Vitro Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global In-Vitro Diagnostics Revenue Market Share by Type (2024-2029)
Table 9. Global In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global In-Vitro Diagnostics Revenue Market Share by Application (2018-2023)
Table 11. Global In-Vitro Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global In-Vitro Diagnostics Revenue Market Share by Application (2024-2029)
Table 13. Global In-Vitro Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global In-Vitro Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global In-Vitro Diagnostics Market Share by Region (2018-2023)
Table 16. Global In-Vitro Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global In-Vitro Diagnostics Market Share by Region (2024-2029)
Table 18. In-Vitro Diagnostics Market Trends
Table 19. In-Vitro Diagnostics Market Drivers
Table 20. In-Vitro Diagnostics Market Challenges
Table 21. In-Vitro Diagnostics Market Restraints
Table 22. Global Top In-Vitro Diagnostics Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global In-Vitro Diagnostics Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global In-Vitro Diagnostics Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of In-Vitro Diagnostics, Headquarters and Area Served
Table 26. Global In-Vitro Diagnostics Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global In-Vitro Diagnostics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 45. Roche Company Detail
Table 46. Roche Business Overview
Table 47. Roche In-Vitro Diagnostics Product
Table 48. Roche Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 49. Roche Recent Development
Table 50. Siemens Company Detail
Table 51. Siemens Business Overview
Table 52. Siemens In-Vitro Diagnostics Product
Table 53. Siemens Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 54. Siemens Recent Development
Table 55. Abbott Company Detail
Table 56. Abbott Business Overview
Table 57. Abbott In-Vitro Diagnostics Product
Table 58. Abbott Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 59. Abbott Recent Development
Table 60. Danaher Company Detail
Table 61. Danaher Business Overview
Table 62. Danaher In-Vitro Diagnostics Product
Table 63. Danaher Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 64. Danaher Recent Development
Table 65. Thermo Fisher Company Detail
Table 66. Thermo Fisher Business Overview
Table 67. Thermo Fisher In-Vitro Diagnostics Product
Table 68. Thermo Fisher Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 69. Thermo Fisher Recent Development
Table 70. BioMerieux Company Detail
Table 71. BioMerieux Business Overview
Table 72. BioMerieux In-Vitro Diagnostics Product
Table 73. BioMerieux Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 74. BioMerieux Recent Development
Table 75. Bio-Rad Company Detail
Table 76. Bio-Rad Business Overview
Table 77. Bio-Rad In-Vitro Diagnostics Product
Table 78. Bio-Rad Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 79. Bio-Rad Recent Development
Table 80. BD Company Detail
Table 81. BD Business Overview
Table 82. BD In-Vitro Diagnostics Product
Table 83. BD Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 84. BD Recent Development
Table 85. JNJ Company Detail
Table 86. JNJ Business Overview
Table 87. JNJ In-Vitro Diagnostics Product
Table 88. JNJ Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 89. JNJ Recent Development
Table 90. Sysmex Company Detail
Table 91. Sysmex Business Overview
Table 92. Sysmex In-Vitro Diagnostics Product
Table 93. Sysmex Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 94. Sysmex Recent Development
Table 95. KHB Company Detail
Table 96. KHB Business Overview
Table 97. KHB In-Vitro DiagnosticsProduct
Table 98. KHB Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 99. KHB Recent Development
Table 100. DaAn Gene Company Detail
Table 101. DaAn Gene Business Overview
Table 102. DaAn Gene In-Vitro DiagnosticsProduct
Table 103. DaAn Gene Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 104. DaAn Gene Recent Development
Table 105. Leadman Company Detail
Table 106. Leadman Business Overview
Table 107. Leadman In-Vitro DiagnosticsProduct
Table 108. Leadman Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 109. Leadman Recent Development
Table 110. BioSino Company Detail
Table 111. BioSino Business Overview
Table 112. BioSino In-Vitro DiagnosticsProduct
Table 113. BioSino Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 114. BioSino Recent Development
Table 115. BSBE Company Detail
Table 116. BSBE Business Overview
Table 117. BSBE In-Vitro DiagnosticsProduct
Table 118. BSBE Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 119. BSBE Recent Development
Table 120. Maccura Company Detail
Table 121. Maccura Business Overview
Table 122. Maccura In-Vitro DiagnosticsProduct
Table 123. Maccura Revenue in In-Vitro Diagnostics Business (2017-2022) & (US$ Million)
Table 124. Maccura Recent Development
Table 125. Roche Company Information
Table 126. Roche Business Overview
Table 127. Roche In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 128. Roche Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 129. Roche Recent Development
Table 130. Siemens Company Information
Table 131. Siemens Business Overview
Table 132. Siemens In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 133. Siemens Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 134. Siemens Recent Development
Table 135. Abbott Company Information
Table 136. Abbott Business Overview
Table 137. Abbott In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 138. Abbott Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 139. Abbott Recent Development
Table 140. Danaher Company Information
Table 141. Danaher Business Overview
Table 142. Danaher In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 143. Danaher Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 144. Danaher Recent Development
Table 145. Thermo Fisher Company Information
Table 146. Thermo Fisher Business Overview
Table 147. Thermo Fisher In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 148. Thermo Fisher Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 149. Thermo Fisher Recent Development
Table 150. BioMerieux Company Information
Table 151. BioMerieux Business Overview
Table 152. BioMerieux In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 153. BioMerieux Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 154. BioMerieux Recent Development
Table 155. Bio-Rad Company Information
Table 156. Bio-Rad Business Overview
Table 157. Bio-Rad In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 158. Bio-Rad Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 159. Bio-Rad Recent Development
Table 160. BD Company Information
Table 161. BD Business Overview
Table 162. BD In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 163. BD Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 164. BD Recent Development
Table 165. JNJ Company Information
Table 166. JNJ Business Overview
Table 167. JNJ In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 168. JNJ Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 169. JNJ Recent Development
Table 170. Sysmex Company Information
Table 171. Sysmex Business Overview
Table 172. Sysmex In-Vitro Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 173. Sysmex Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 174. Sysmex Recent Development
Table 175. KHB Company Information
Table 176. KHB Business Overview
Table 177. KHB In-Vitro DiagnosticsRevenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 178. KHB Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 179. KHB Recent Development
Table 180. DaAn Gene Company Information
Table 181. DaAn Gene Business Overview
Table 182. DaAn Gene In-Vitro DiagnosticsRevenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 183. DaAn Gene Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 184. DaAn Gene Recent Development
Table 185. Leadman Company Information
Table 186. Leadman Business Overview
Table 187. Leadman In-Vitro DiagnosticsRevenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 188. Leadman Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 189. Leadman Recent Development
Table 190. BioSino Company Information
Table 191. BioSino Business Overview
Table 192. BioSino In-Vitro DiagnosticsRevenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 193. BioSino Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 194. BioSino Recent Development
Table 195. BSBE Company Information
Table 196. BSBE Business Overview
Table 197. BSBE In-Vitro DiagnosticsRevenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 198. BSBE Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 199. BSBE Recent Development
Table 200. Maccura Company Information
Table 201. Maccura Business Overview
Table 202. Maccura In-Vitro DiagnosticsRevenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 203. Maccura Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 204. Maccura Recent Development
Table 205. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. In-Vitro Diagnostics Product Picture
Figure 5. Global In-Vitro Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global In-Vitro Diagnostics Market Share by Type: 2022 VS 2029
Figure 7. Tissue Diagnostics Product Picture
Figure 8. Professional Diagnostic Product Picture
Figure 9. Molecular Diagnostic Product Picture
Figure 10. Diabetes Monitoring Product Picture
Figure 11. Other Product Picture
Figure 12. Global In-Vitro Diagnostics Market Size by Application (2023-2029) & (US$ Million)
Figure 13. Global In-Vitro Diagnostics Market Share by Application: 2022 VS 2029
Figure 14. Diabetes Product Picture
Figure 15. Infectious Diseases Product Picture
Figure 16. Oncology Product Picture
Figure 17. Cardiology Product Picture
Figure 18. HIV Product Picture
Figure 19. Other Product Picture
Figure 20. Global In-Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 21. Global In-Vitro Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 22. Global In-Vitro Diagnostics Market Share by Region: 2022 VS 2029
Figure 23. Global In-Vitro Diagnostics Market Share by Players in 2022
Figure 24. Global In-Vitro Diagnostics Players, Date of Enter into This Industry
Figure 25. Global Top 5 and 10 In-Vitro Diagnostics Players Market Share by Revenue in 2022
Figure 26. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 27. North America In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. North America In-Vitro Diagnostics Market Share by Country (2018-2029)
Figure 29. United States In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Canada In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Europe In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Europe In-Vitro Diagnostics Market Share by Country (2018-2029)
Figure 33. Germany In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. France In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. U.K. In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Italy In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Russia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Nordic Countries In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Asia-Pacific In-Vitro Diagnostics Market Share by Country (2018-2029)
Figure 41. China In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Japan In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Latin America In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Latin America In-Vitro Diagnostics Market Share by Country (2018-2029)
Figure 49. Mexico In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Brazil In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Middle East & Africa In-Vitro Diagnostics Market Share by Country (2018-2029)
Figure 53. Turkey In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. UAE In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Roche Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 57. Siemens Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 58. Abbott Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 59. Danaher Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 60. Thermo Fisher Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 61. BioMerieux Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 62. Bio-Rad Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 63. BD Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 64. JNJ Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 65. Sysmex Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 66. KHB Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 67. DaAn Gene Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 68. Leadman Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 69. BioSino Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 70. BSBE Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 71. Maccura Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. In-Vitro Diagnostics Product Picture
Figure 5. Global In-Vitro Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global In-Vitro Diagnostics Market Share by Type: 2022 VS 2029
Figure 7. Tissue Diagnostics Product Picture
Figure 8. Professional Diagnostic Product Picture
Figure 9. Molecular Diagnostic Product Picture
Figure 10. Diabetes Monitoring Product Picture
Figure 11. Other Product Picture
Figure 12. Global In-Vitro Diagnostics Market Size by Application (2023-2029) & (US$ Million)
Figure 13. Global In-Vitro Diagnostics Market Share by Application: 2022 VS 2029
Figure 14. Diabetes Product Picture
Figure 15. Infectious Diseases Product Picture
Figure 16. Oncology Product Picture
Figure 17. Cardiology Product Picture
Figure 18. HIV Product Picture
Figure 19. Other Product Picture
Figure 20. Global In-Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 21. Global In-Vitro Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 22. Global In-Vitro Diagnostics Market Share by Region: 2022 VS 2029
Figure 23. Global In-Vitro Diagnostics Market Share by Players in 2022
Figure 24. Global In-Vitro Diagnostics Players, Date of Enter into This Industry
Figure 25. Global Top 5 and 10 In-Vitro Diagnostics Players Market Share by Revenue in 2022
Figure 26. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 27. North America In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. North America In-Vitro Diagnostics Market Share by Country (2018-2029)
Figure 29. United States In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Canada In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Europe In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Europe In-Vitro Diagnostics Market Share by Country (2018-2029)
Figure 33. Germany In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. France In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. U.K. In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Italy In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Russia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Nordic Countries In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Asia-Pacific In-Vitro Diagnostics Market Share by Country (2018-2029)
Figure 41. China In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Japan In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Latin America In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Latin America In-Vitro Diagnostics Market Share by Country (2018-2029)
Figure 49. Mexico In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Brazil In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Middle East & Africa In-Vitro Diagnostics Market Share by Country (2018-2029)
Figure 53. Turkey In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. UAE In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Roche Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 57. Siemens Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 58. Abbott Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 59. Danaher Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 60. Thermo Fisher Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 61. BioMerieux Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 62. Bio-Rad Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 63. BD Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 64. JNJ Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 65. Sysmex Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 66. KHB Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 67. DaAn Gene Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 68. Leadman Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 69. BioSino Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 70. BSBE Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 71. Maccura Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
